Sandesh Mahatme, EVP, CFO & CBO at Sarepta Therapeutics, Inc. (SRPT), sold 50,000 shares at $41.00 ($2.0M) on 2017-07-20, disclosed to the SEC on 2017-07-21.
Open-market sale of $2.0M SRPT by EVP, CFO & CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.00 | 7,627 | $313K | 15.3% |
| 2 | $41.00 | 9,375 | $384K | 18.8% |
| 3 | $41.00 | 32,998 | $1.4M | 66.0% |
| Total | $41.00 avg | 50,000 | $2.0M | 100% |
| Filing → |
| SRPT | SELL | 2019-02-01 | $8.5M | — | Filing → |
| SRPT | SELL | 2018-10-26 | $27.5M | — | Filing → |
| SRPT | SELL | 2016-10-19 | $1.5M | — | Filing → |